SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-21-000150
Filing Date
2021-08-05
Accepted
2021-08-05 16:41:08
Documents
81
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvnc-20210630.htm   iXBRL 10-Q 2126906
2 EX-10.1 rvncq221exhibit101.htm EX-10.1 383746
3 EX-31.1 rvncq221exhibit311.htm EX-31.1 8788
4 EX-31.2 rvncq221exhibit312.htm EX-31.2 8786
5 EX-32.1 rvncq221exhibit321.htm EX-32.1 6510
6 EX-32.2 rvncq221exhibit322.htm EX-32.2 6534
  Complete submission text file 0001479290-21-000150.txt   8868021

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20210630.xsd EX-101.SCH 49563
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20210630_cal.xml EX-101.CAL 82053
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20210630_def.xml EX-101.DEF 268344
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20210630_lab.xml EX-101.LAB 619818
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20210630_pre.xml EX-101.PRE 414828
12 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20210630_htm.xml XML 1451481
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 211149013
SIC: 2834 Pharmaceutical Preparations